Cyclo Therapeutics, Inc.·4

Dec 2, 4:34 PM ET

FINE N SCOTT 4

4 · Cyclo Therapeutics, Inc. · Filed Dec 2, 2021

Insider Transaction Report

Form 4
Period: 2021-12-02
FINE N SCOTT
Director
Transactions
  • Purchase

    Common Stock

    2021-12-02$4.93/sh+5,000$24,650124,666 total
Footnotes (1)
  • [F1]The price reported is a weighted average price. These shares of common stock were purchased in multiple transactions at prices ranging from $4.915 to $4.96, inclusive. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the foregoing ranges.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4